856 results on '"Erbersdobler, Andreas"'
Search Results
52. Supplementary Methods, Figures 1-6, Tables A-C from Targeting Activin Receptor-Like Kinase 1 Inhibits Angiogenesis and Tumorigenesis through a Mechanism of Action Complementary to Anti-VEGF Therapies
53. Recurrent sigmoid volvulus secondary to a large pedunculated colonic lipoma.
54. Rare ADAR and RNASEH2B variants and a type I interferon signature in glioma and prostate carcinoma risk and tumorigenesis
55. Synchrone Demonstration einer frei verfügbaren interprofessionellen Datenbank für 3D-Makroskopie und digitale Mikroskopie
56. Comparing tumor microRNA profiles of patients with long‑ and short‑term‑surviving glioblastoma
57. Evaluation of the Cellular Dissociation Grading, Based on Tumor Budding and Cell Nest Size, in Squamous Cell Carcinoma of the Penis
58. CMTM6 and PD-L1 are independent prognostic biomarkers in head and neck squamous cell carcinoma
59. Prostate cancer with Paneth cell–like neuroendocrine differentiation has recognizable histomorphology and harbors AURKA gene amplification
60. Peliosis of the Liver and Spleen : Pathological Features and Forensic Pathological Relevance of Two Rare Diseases With Potentially Fatal Outcome
61. Prostatic adenocarcinoma metastasizing to a clear cell renal cell carcinoma: Report of a case
62. Protein gene product 9.5 is diagnostically helpful in delineating high-grade renal cell cancer involving the renal medullary/sinus region from invasive urothelial cell carcinoma of the renal pelvis
63. Concurrent AURKA and MYCN Gene Amplifications Are Harbingers of Lethal TreatmentRelated Neuroendocrine Prostate Cancer
64. p16INK4a is a Marker of Good Prognosis for Primary Invasive Penile Squamous Cell Carcinoma: A Multi-Institutional Study
65. An Extremely Rare Cause of an Obstructive Jaundice in Adults: Limited Langerhans Cell Histiocytosis of the Extrahepatic Bile Duct
66. Rare germline variants in the tumor suppressor gene CDH1 in glioma families and gastric cancer families with brain tumors
67. Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago
68. Gastric lanthanosis (lanthanum deposition) in an immunosuppressed patient that discontinued lanthanum carbonate seven years ago
69. Predictive Value of Prostate-specific Antigen Expression in Prostate Cancer: A Tissue Microarray Study
70. VEGFR-1 expression levels predict occurrence of disseminated tumor cells in the bone marrow of patients with esophageal carcinoma
71. Correction to: EGFR and BRAF mutations in inverted sinonasal papilloma—a more complex landscape?
72. Validation of the Contemporary Epstein Criteria for Insignificant Prostate Cancer in European Men
73. Clinical significance of p53 alterations in surgically treated prostate cancers
74. Direct Genetic Analysis of Single Disseminated Cancer Cells for Prediction of Outcome and Therapy Selection in Esophageal Cancer
75. Marked Gene Transcript Level Alterations Occur Early During Radical Prostatectomy
76. Assessment of Biochemical Recurrence Rate in Patients With Pathologically Confirmed Insignificant Prostate Cancer
77. Prognostic value of microvessel density in prostate cancer: a tissue microarray study
78. Nuclear Grading Versus Gleason Grading in Small Samples Containing Prostate Cancer: A Tissue Microarray Study
79. MUC1 Expression in Incidental Prostate Cancer Predicts Staging and Grading on the Subsequent Radical Prostatectomy
80. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays
81. Expression of prostatic acid phosphatase (PSAP) in transurethral resection specimens of the prostate is predictive of histopathologic tumor stage in subsequent radical prostatectomies
82. Molecular staging of prostate cancer in the year 2007
83. Book reviews
84. Development and External Validation of an Extended 10-Core Biopsy Nomogram
85. Development and Split-Sample Validation of a Nomogram Predicting the Probability of Seminal Vesicle Invasion at Radical Prostatectomy
86. Zonal Origin of Localized Prostate Cancer Does not Affect the Rate of Biochemical Recurrence after Radical Prostatectomy
87. Nerve Distribution along the Prostatic Capsule
88. Development and External Validation of an Extended Repeat Biopsy Nomogram
89. Papillary Fibroelastoma in Differential Diagnosis of Left Atrial Appendage Masses
90. The human tumor suppressor CEACAM1 modulates apoptosis and is implicated in early colorectal tumorigenesis
91. Comparison of the ImmunoCyt test and urinary cytology with other urine tests in the detection and surveillance of bladder cancer
92. Characterisation of biomolecular profiles in primary high-grade prostate cancer treated by radical prostatectomy
93. High Incidence of Prostate Cancer Detected by Saturation Biopsy after Previous Negative Biopsy Series
94. Frozen Section for the Management of Intraoperatively Detected Palpable Tumor Lesions During Nerve-Sparing Scheduled Radical Prostatectomy
95. From Gene to Clinic: TMA-Based Clinical Validation of Molecular Markers in Prostate Cancer
96. Development and Internal Validation of a Nomogram Predicting the Probability of Prostate Cancer Gleason Sum Upgrading Between Biopsy and Radical Prostatectomy Pathology
97. The 2002 AJCC pT2 Substages Confer No Prognostic Information on the Rate of Biochemical Recurrence After Radical Prostatectomy
98. Development and internal validation of preoperative transition zone prostate cancer nomogram
99. Validation of a Nomogram for Prediction of Side Specific Extracapsular Extension at Radical Prostatectomy
100. Scoring the percentage of Ki67 positive nuclei is superior to mitotic count and the mitosis marker phosphohistone H3 (PHH3) in terms of differentiating flat lesions of the bladder mucosa
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.